MyHealthTeam’s Post

🚀 Dive into our latest report on Digital Therapeutics – Thematic Intelligence! 📈 Gain market insights by region, discover cutting-edge case studies, and explore disruptive product profiles! 💡 Uncover key trends shaping the landscape and understand their impact on market acceleration. 🌟 Assess leaders and disruptors in critical therapeutic areas! Don't miss out on the future of digital health! Read the report now! https://lnkd.in/gQpCuMwa #healthcare #digitalhterapeutics #healthcareinnovation #futureofhealthcare 

Looking very much forward to hear the thoughts of the participants on digital endpoints in clinical studies. 👩🔬 #cosinuss #rpm #remotepatientmonitoring #clinicalstudies #pharma #biotech #digitalbiomarkers #digitalhealth #vitalsigns

🌟 Revolutionizing Medicine with DoseMe! 🌟 I had an enlightening conversation with Paul Edwards, the President & CEO of DoseMe, on the latest episode of the Life Science Success Podcast! 🎙️ Here are some key takeaways: Precision in Dosing: DoseMeRx is pioneering precise dosing for critically ill patients, enhancing the efficacy and safety of injectable antibiotics with innovative therapeutic drug monitoring. 💉🔬 Industry Insight: Paul's extensive experience, from leading roles at Merck and GSK to transformative startups, underscores the critical role of real-world data in advancing personalized medicine. 🌍📊 Antimicrobial Stewardship: Emphasizing the importance of antimicrobial stewardship, Paul discusses how DoseMeRx’s technology supports clinicians in delivering the right dose at the right time, improving patient outcomes. 🏥👨⚕️ Future of Medicine: We explored the potential of pharmacogenomics and personalized medicine in shaping the future of healthcare, aiming for treatments tailored to individual patient needs. 🧬🚀 Overcoming Challenges: Addressing current insurance and payment system limitations, Paul highlights the need for systems that better support precision and personalized medicine. 🏛️⚖️ A huge thanks to Paul for sharing his insights and to D3 Digital Media Marketing for sponsoring this episode. Let’s continue to innovate and drive success in life sciences! 👉 Listen to the full episode and join the conversation on advancing healthcare: https://lnkd.in/gn63phKa #LifeScienceSuccess #DoseMeRx #PrecisionMedicine #Pharmacogenomics #DigitalMarketing #HealthcareInnovation #AntimicrobialStewardship

Saying 'expect the unexpected' sounds like a marital arts movie cliche, but these days this seems to be the norm in the digital health space. Aptar and Biogen have announced a commericialisation deal covering a set of digital health products. I was expecting to see Biogen licensing an Aptar digital health solution, however the opposite is true and Aptar is licensing Biogen's products. So in an about turn of the story that pharma companies can provide a path to market for digital health companies here we have a digital health company providing a path to market for a pharma company's digital health products. The basis of the deal makes a lot of sense. Aptar will handle all development work and patient engagement for the digital products, which makes sense since both activities are not core capabilities of a pharma company. There are still areas that Biogen could support, such as HCP engagement and market access and reimbursement, but the announcement seems to point in the direction that Aptar will be taking over all activity related to the digital health products. Its great to see Biogen's innovative digital health products find new ways to reach patients, and congratulations to the Aptar team on closing the deal. #digitalhealthcare #digitalhealth

Why would pharma invest in building and sustaining next generation digital companion apps that benefit patients and/or healthcare professionals? Most likely because there is a business case that supports it. In this article we break down some of the key value drivers for pharma, and how digital companions can be "win-win"👇 https://lnkd.in/dBxT9sM8 #digitalhealth #alextherapeutics #digitalcompanion #pharma

Thanks for sharing insights, successful CGT delivery strategies needs a holistic appoarch which considers clinical interactions, flexible manufacturing, RWE data and innovative payment models. Leveraging the data continum throughout will accelerate learnings, reduce CoG, reduce risk/delivery uncertainty and drive efficiency. #celltherapy #genetherapy #cdmo IQVIA #regenerativemedicine #immunotherapy https://lnkd.in/ebDfhr2t

"Gen AI is increasingly being applied to many functions in the pharmaceutical, medical-device, and healthcare fields." (Mckinsey & Company: "Public health’s inflection point with generative AI) #genai #generatieveai #

Is AI like a superhero for healthcare?    Building on the topic of my previous post regarding AI in healthcare, I'd like to share the example of a big pharmaceutical company, Takeda, using AI, that caught my attention recently. Normally, we hear about AI helping with managing clinical data, automating processes, etc.   Takeda is all about developing treatments and vaccines for celiac disease to rare autoimmune disorders. They responsibly adopt AI, using it for developing new medicines and optimizing treatments.    Now, Takeda, along with Zedira and Dr. Falk Pharma join at work on TAK-227 for celiac disease, an autoimmune disease triggered by gluten consumption, causing small intestine inflammation and damage. TAK-227 aims to calm down the immune system when gluten shows up, which could be a game-changer for people dealing with celiac. This collaboration fills a critical gap in treating such diseases, where approved therapies are lacking.   What are your thoughts on it? Is AI a real superhero for healthcare?

Samuel Whitaker Whitaker and Jason Dong, co-founders of Mural Health, recently shared their predictions with PharmaVoice on how they believe the industry will develop in 2024. “We hope to see a heightened focus in the industry on removing financial barriers to clinical trial participation — barriers that disproportionately affect people from lower socioeconomic and minority groups and result in a lack of diversity that threatens the efficacy of the drug development process.” To read more, including predictions from other industry leaders, click here: https://ow.ly/xYIn50QrOLh #ClinicalTrialResearch #PatientAdvocates

🌟#IgNS2024 Advanced Practice Session Spotlight!🌟 Join our expert speaker Colin Edgerton MD, FACP at #IgNS2024 and delve into the intricate connection between inflammation and autoimmunity. Discover the underlying mechanisms and the latest research and strategies in managing of these complex disorders. 🔬 Learn more about the exciting agenda, events, and networking opportunities. Register now to secure your spot at this premier event ➡️ https://lnkd.in/gkRqtPHQ #IgNS #SessionSpotlight #Autoimmunity #Inflammation #Healthcare #Conference #Biologics